Real-world use and clinical outcomes among patients with atrial fibrillation using low-dose edoxaban and apixaban in Italy

Real-world use and clinical outcomes among patients with atrial fibrillation using low-dose edoxaban and apixaban in Italy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Real-world use and clinical outcomes among patients with atrial fibrillation using low-dose edoxaban and apixaban in Italy have?

Real-world use and clinical outcomes among patients with atrial fibrillation using low-dose edoxaban and apixaban in Italy has 0 citations in the OpenAlex counts ScholarIQ stores.

When was Real-world use and clinical outcomes among patients with atrial fibrillation using low-dose edoxaban and apixaban in Italy published?

Real-world use and clinical outcomes among patients with atrial fibrillation using low-dose edoxaban and apixaban in Italy has 2025 year in the ScholarIQ index.

What is the open-access status of Real-world use and clinical outcomes among patients with atrial fibrillation using low-dose edoxaban and apixaban in Italy?

Real-world use and clinical outcomes among patients with atrial fibrillation using low-dose edoxaban and apixaban in Italy has hybrid oa status in the ScholarIQ index.

What is the DOI of Real-world use and clinical outcomes among patients with atrial fibrillation using low-dose edoxaban and apixaban in Italy?

The DOI for Real-world use and clinical outcomes among patients with atrial fibrillation using low-dose edoxaban and apixaban in Italy is on the source record.

What is the OpenAlex record for Real-world use and clinical outcomes among patients with atrial fibrillation using low-dose edoxaban and apixaban in Italy?

The OpenAlex for Real-world use and clinical outcomes among patients with atrial fibrillation using low-dose edoxaban and apixaban in Italy is on the source record.